San Mateo, CA, May 22, 2017 -- Evidation Health today announces the results from a study examining the association between behavioral traits inferred from passive trackers and self-reported overall health, physical health, mental health and quality of life (QoL) at ISPOR. ISPOR’s meeting is one of the world’s largest conferences for health economics and outcomes research, with this year’s meeting anticipated to draw more than 3,800 attendees, from 80+ countries.
|
|||
It is well known that behavioral factors can have a profound effect on health outcomes and perceived quality of life. This study extends prior research by quantifying the link between behavioral data, including step and sleep data from activity trackers, and perceived health and QoL in the general population.
“Digital methods have allowed us to expand our understanding of real-world behaviors, and their impact on health outcomes, outside of the traditional clinical trial setting,” said Jessie Juusola, Ph.D., Head of Health Outcomes Research at Evidation Health and the senior author on the study. “The findings from this study will inform the design of future studies quantifying the impact of healthcare interventions on perceived quality of life among disease-specific populations.”
The poster “Digital Trackers Show That High Intensity Exercising And Consistent Sleep Patterns Are Associated With Positive Self-Reported Health Status,” identified by code PHP223, will be displayed at ISPOR’s 22nd Annual International Meeting, from 8:30 a.m. to 2:00 p.m. EST today, with an author-led discussion on the 7000+ participant study beginning at 1:00 p.m. EST.
Authors of the study include: Shefali Kumar, MPH, Health Outcomes Research Senior Associate, Thomas Quisel, BS, Principal Data Scientist, Luca Foschini, PhD, Chief Data Scientist and Jessie Juusola, PhD, Head of Health Outcomes Research from Evidation Health.
About Evidation Health
Evidation Health helps healthcare companies quantify outcomes in the digital era, with real life data from connected patients. The company developed its Real Life Study Platform to accelerate and enhance outcomes research through large-scale virtualized pragmatic trials-- collecting novel digital signals and measuring the impact of digital health and traditional interventions far more efficiently than conventional approaches. Evidation Health works across the healthcare ecosystem with top pharmaceutical companies, payers, providers, and digital healthcare companies. Evidation Health is a privately held company headquartered in San Mateo, CA. For more information, visit www.evidation.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/232ce178-5c9d-40fd-a042-59f17bfddbcf
Polly Israni Evidation Health, Inc. [email protected]


Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
Sam Altman Criticizes ICE Enforcement as Corporate Leaders Call for De-Escalation
Anthropic Raises 2026 Revenue Outlook by 20% but Delays Path to Profitability
Woodside Energy Flags Lower 2026 Production Outlook Despite Strong Q4 Revenue Beat
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
ASML’s EUV Monopoly Powers the Global AI Chip Boom
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results
Ford and GM Near Financing Deal to Support First Brands Group During Bankruptcy
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company
Google Disrupts Major Residential Proxy Network IPIDEA
SoftBank Shares Surge as It Eyes Up to $30 Billion New Investment in OpenAI
C3.ai in Merger Talks With Automation Anywhere as AI Software Industry Sees Consolidation
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges 



